Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report

TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV react...

Descripción completa

Detalles Bibliográficos
Autores principales: Colaci, Michele, Sebastiani, Marco, Sandri, Gilda, Meacci, Marisa, Ferri, Clodoveo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336221/
https://www.ncbi.nlm.nih.gov/pubmed/22570799
http://dx.doi.org/10.1155/2011/530568
_version_ 1782230889203236864
author Colaci, Michele
Sebastiani, Marco
Sandri, Gilda
Meacci, Marisa
Ferri, Clodoveo
author_facet Colaci, Michele
Sebastiani, Marco
Sandri, Gilda
Meacci, Marisa
Ferri, Clodoveo
author_sort Colaci, Michele
collection PubMed
description TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.
format Online
Article
Text
id pubmed-3336221
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33362212012-05-08 Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report Colaci, Michele Sebastiani, Marco Sandri, Gilda Meacci, Marisa Ferri, Clodoveo Case Rep Infect Dis Case Report TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab. Hindawi Publishing Corporation 2011 2011-06-30 /pmc/articles/PMC3336221/ /pubmed/22570799 http://dx.doi.org/10.1155/2011/530568 Text en Copyright © 2011 Michele Colaci et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Colaci, Michele
Sebastiani, Marco
Sandri, Gilda
Meacci, Marisa
Ferri, Clodoveo
Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
title Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
title_full Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
title_fullStr Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
title_full_unstemmed Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
title_short Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
title_sort epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336221/
https://www.ncbi.nlm.nih.gov/pubmed/22570799
http://dx.doi.org/10.1155/2011/530568
work_keys_str_mv AT colacimichele epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport
AT sebastianimarco epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport
AT sandrigilda epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport
AT meaccimarisa epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport
AT ferriclodoveo epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport

Ejemplares similares